Dorsey Wright & Associates Zymeworks Inc. Put Options Transaction History
Dorsey Wright & Associates
- $376 Million
- Q2 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding ZYME
# of Institutions
1Shares Held
296KCall Options Held
0Put Options Held
0About Zymeworks Inc.
- Ticker ZYME
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,694,400
- Market Cap $671M
- Description
- Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...